Methods for assessing risk of developing a viral disease using a genetic test

US10563264B2 · kind B2 · utility

Assignees

• PML Screening, LLC · US
• UNIVERSITÉ PARIS-SUD · DE
• ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
• Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

• Eli Hatchwell · Smithtown, US
• Peggy S. Eis · Fitchburg, US
• Edward B. Smith, III · Seattle, US
• Yassine Taoufik · Paris, FR

Key dates

• Filing date: Aug 16, 2019
• Grant date: Feb 18, 2020
• Expiry date: Aug 16, 2039

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/52
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject's disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test.